EN DE

Nynomic AG (M7U) Fair Value & Analysis

Technology · DE · Market cap €104M

NA Nynomic AG M7U · XETRA
Price€17.45
Fair Value€9.87
Upside-43.4%
Quality50/100
Watch Nynomic AG for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -0.8% net margin
Low debt · generates free cash flow
Mixed vs. peers (5/12)
Narrow moat 29/100
Evidence: Medium Range €7.28 – €12.47 Share as image

Fair value as of: Jul 15, 2026

From 13 valuation models · updated 26 days ago

Fair value updated Jul 15, 2026, revised from €10.85 to €9.87 (−9.0%) since Jun 24, 2026. Share price +8.0% over the past month.

A solid business, but screening 43% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (€12.47). The favourable scenario is already priced in.
  • Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€54.40 €8.36 Fair Value €9.87 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.

How to read this chart

60‑month range €8.36 – €54.40 · fair‑value band €7.28 – €12.47 · the €17.45 price screens above the €9.87 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 15, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Nynomic AG (M7U) currently trades at €17.45, while our model-based Fair Value estimate is €9.87, implying the stock looks roughly 43.4% overvalued today. The Quality Score stands at 50/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Nynomic AG generated revenue of €97.7M at a net margin of -6.8%. Revenue declined 11.6% year over year. It earns a return on equity of -2.2%. Net debt stands at €3.4M. Fundamentals as of Jul 15, 2026

Our scenario range runs from €7.28 (bear case) to €12.47 (bull case); at €17.45, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 34% below its 52-week high and 112% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at -45% fair-value upside, at -43%, M7U screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF €9.33 €11.55 €14.10 80
Rev-Margin DCF €9.49 €13.36 €17.72 74
Gordon GGM €0.7500 €1.26 €1.63 70
All 13 models by family
DCF Models
FCF DCF €9.29 €11.83 €14.92 38
Owner Earnings €6.77 €8.41 €10.40 31
5Y Revenue Exit €9.49 €13.30 €18.05 39
5Y EBITDA Exit €9.13 €12.64 €16.61 41
10Y Revenue Exit €9.14 €12.22 €16.17 36
10Y EBITDA Exit €9.12 €11.84 €15.25 37
Dividend Discount
Gordon GGM €0.7500 €1.26 €1.63 70
DDM Multi-Stage €0.7500 €1.09 €1.35 61
Multiples
EV/EBITDA €9.97 €12.57 €15.16 54
EV/Revenue €10.13 €13.54 €16.95 43
Asset-Based
NCAV (Graham) €7.33 €9.83 €14.67 50
Growth DCF
Growth DCF €9.33 €11.55 €14.10 80
Rev-Margin DCF €9.49 €13.36 €17.72 74

Widest divergence: Multiples (€12.57) versus Dividend Discount (€1.09). Highest evidence: Growth DCF (80).

Notify me when M7U reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) €93.2M
Revenue growth (YoY) -11.6%
Net margin -0.8%
Return on equity -0.3%
Free cash flow €5.7M FY2025
Operating margin 7.8%
More key figures
EPS (TTM) €-0.1100
EPS growth (YoY) -1.6%
Net debt €3.4M FY2025

Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 51 · Market factors (momentum, volatility) 54

Profitability 21
Margins and returns on capital today
Quality Growth 16
Are margins and returns improving?
Cashflow 49
Earnings quality: real cash, not paper profit
Fin. Strength 84
Balance sheet, leverage, solvency risk
Investment 82
Disciplined investing over empire-building
Low Volatility 28
Calm price path (market factor)
Momentum 65
Price trend over the last 3–12 months (market factor)
52W Momentum 64
Distance to the 52-week high (market factor)
Net Issuance 62
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Nynomic AG, together with its subsidiaries, manufactures and sells products for permanent, non-contact, and non-destructive optical measurement technology.

Full company description

Nynomic AG, together with its subsidiaries, manufactures and sells products for permanent, non-contact, and non-destructive optical measurement technology. The company also supplies customized system solutions in the areas of control engineering, sensor technology, and laboratory automation or spectrometry; components and systems for industrial optical spectroscopy, including UV-VIS-NIR and Raman diode array spectroscopy with associated software solutions; and develops and manufactures optical measurement systems for various applications. In addition, it provides spectrometers, light sources for UV, VIS, and NIR, as well as fibre optics or optical waveguides, accessories, and customer-specific products for OEM applications, as well as scientific market; optical measurement and control technology systems; process-integrated measurement technology solutions; and hardware and software systems for digital plant phenotyping and high-throughput screening fields. Further, the company develops, produces, and distributes infrared measurement technology; development and manufacture of test and calibration equipment for cameras and multi-sensor systems; micro-incandescent lamps, lenses, and special lamps; and special fibres for optical measurement technology. The company was formerly known as m-u-t AG and changed its name to Nynomic AG in August 2018. Nynomic AG was incorporated in 1995 and is headquartered in Wedel, Germany.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Nynomic AG reported revenue of €92.6M in FY2025 versus €105M in FY2021, a compound −3.1%/yr. Reported net income was −€704K in FY2025.

Growth Quality 31/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
€92.6M
Latest YoY
−9.6%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−7.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.3%
Avg. growth/yr (16Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.7%
Revenue −3.1%/yr
FY21 €105M
FY22 €117M
FY23 €118M
FY24 €102M
FY25 €92.6M
Net income
FY21 €7.9M
FY22 €7.5M
FY23 €9.3M
FY24 −€643K
FY25 −€704K

M7U screens 43% overvalued. Compare with Keysight Technologies, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Nynomic AG Fair Value". https://www.fairvalue-calculator.com/stock/M7U

Peer Group

Scientific & Technical Instruments · 161 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 50 · Below median
Fair Value upside −43% · Above median
Return on assets 1% · Below median
Net margin (TTM) -1% · Bottom 25%
Operating margin (TTM) 8% · Above median
Revenue growth -12% · Bottom 25%
Debt / equity 0.00× · Lower than median

Valuation Multiples vs Scientific & Technical Instruments median · lower = cheaper

P/B 1.25× · Cheaper than median
P/S (TTM) 1.29× · Cheaper than median
P/FCF 21.0× · Pricier than median
EV/EBITDA 22.5× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 34
PAST 0 · sector 25
HEALTH 100 · sector 98
DIVIDEND 0 · sector 24

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $315.90 $84.16 -73%
Garmin Ltd GRMN $241.76 $146.67 -39%
Teledyne Technologies Incorporated TDY $635.52 $367.58 -42%
Chroma ATE Inc 2360 1,905 TWD 286.15 TWD -85%
Hexagon AB HEXAB kr 80.10 kr 52.93 -34%
MKS Inc MKSI $324.69 $77.46 -76%
AVIC Chengdu Aircraft Company 302132 ¥52.91 ¥34.47 -35%
Fortive Corporation FTV $61.78 $33.84 -45%
Trimble Inc TRMB $52.72 $24.47 -54%
Cognex Corporation CGNX $64.07 $13.75 -79%

Compare Nynomic AG with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Nynomic AG (M7U) overvalued or undervalued?
As of Jul 15, 2026, our model estimates a fair value of €9.87 versus a price of €17.45, about −43% (overvalued).
What is the fair value of M7U?
Our model-based fair value for Nynomic AG is €9.87 (as of Jul 15, 2026), built from audited fundamentals. The current price is €17.45.
What is the quality score of M7U?
Nynomic AG has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Nynomic AG (M7U)?
Nynomic AG reported trailing-twelve-month revenue of about €97.7M (latest available figure, as of Jul 15, 2026).
What is the net profit margin of M7U?
The net profit margin of Nynomic AG is about -6.8%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Nynomic AG and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.